DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
7.71
+0.12 (1.58%)
Mar 6, 2026, 4:00 PM EST - Market closed
DiaMedica Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 413 | 232 | 108 | 42 | 99 | 190 | |
| Market Cap Growth | 46.17% | 115.41% | 157.97% | -57.63% | -48.10% | 226.30% | |
| Enterprise Value | 358 | 182 | 52 | 6 | 51 | 160 | |
| Last Close Price | 7.71 | 5.43 | 2.84 | 1.58 | 3.73 | 10.14 | |
| PB Ratio | 7.78 | 5.70 | 2.11 | 1.31 | 2.24 | 7.30 | |
| P/TBV Ratio | 8.00 | 5.70 | 2.11 | 1.31 | 2.24 | 7.30 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.00 | 0.01 | |
| Net Debt / Equity Ratio | -1.07 | -1.08 | -1.03 | -1.04 | -1.02 | -1.05 | |
| Net Debt / EBITDA Ratio | 1.64 | 1.64 | 2.47 | 2.36 | 3.31 | 2.16 | |
| Net Debt / FCF Ratio | 1.98 | 1.98 | 2.80 | 2.85 | 3.67 | 2.97 | |
| Quick Ratio | 10.55 | 8.23 | 19.12 | 15.49 | 29.69 | 13.73 | |
| Current Ratio | 10.67 | 8.28 | 19.27 | 15.61 | 29.82 | 13.77 | |
| Return on Equity (ROE) | -64.12% | -53.27% | -46.77% | -36.06% | -38.81% | -73.10% | |
| Return on Assets (ROA) | -38.34% | -33.18% | -30.02% | -21.89% | -23.16% | -42.73% | |
| Return on Capital Employed (ROCE) | -64.90% | -65.10% | -41.40% | -43.40% | -31.00% | -48.70% | |
| Earnings Yield | -7.73% | -10.53% | -17.98% | -32.73% | -13.78% | -6.47% | |
| FCF Yield | -6.72% | -9.52% | -17.40% | -27.74% | -12.45% | -4.86% | |
| Buyback Yield / Dilution | -13.70% | -24.07% | -23.16% | -27.29% | -32.48% | -30.80% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.